Allogene Therapeutics
Allogene Therapeutics, based in South San Francisco, CA, is at the forefront of cell therapy innovation, focusing on the development of AlloCAR T products for blood cancers, solid tumors, and autoimmune diseases. Their pioneering platform leverages multiplex gene-engineering and state-of-the-art manufacturing techniques to deliver scalable, on-demand treatment solutions.
The company is currently conducting pivotal clinical trials, including the ALPHA3 trial, which assesses an investigational allogeneic CAR T therapy for large-B cell lymphoma. With a mission to redefine the future of cell therapy, Allogene Therapeutics aims to provide effective treatment options with the potential to serve multiple patients from a single production run.
Generated from the website
You might also like
Partial Data by Foursquare.